ModelEdge

Axsome Therapeutics Inc.
AXSM
Filing Type10-K
Filing Date2/22/2024
Updated2/23/24, 1:10 AM

Filing

10-K
Earnings Release

Exhibits

10-KFY 2023
EX-10.2AXSOME THERAPEUTICS, INC. AMENDED AND RESTATED 2015 OMNIBUS INCENTIVE COMPENSATION PLAN
EX-19.1AXSOME THERAPEUTICS, INC. INSIDER TRADING COMPANY
EX-21.1SUBSIDIARIES OF THE COMPANY
EX-23.1CONSENT OF DELOITTE & TOUCHE LLP
EX-23.2CONSENT OF ERNST & YOUNG LLP
EX-31.1CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
EX-31.2CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
EX-32.1EX-32.1
EX-32.2EX-32.2
EX-97.1AXSOME THERAPEUTICS, INC. DODD-FRANK CLAWBACK POLICY
GRAPHICGraphic
GRAPHICGraphic